Grossi Federico
Insider CIK 1720634 · UBX Chief Medical Officer · APLS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| UBX Unity Biotechnology, Inc. | A Award deriv | 2025-01-06 | 2025-01-07 | 150,000 | — | $0 | 150,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-01-05 | 2023-01-09 | 2,500 | $48.79 | $122.0K | 94,884 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-12-01 | 2022-12-02 | 2,500 | $49.93 | $124.8K | 97,384 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-11-01 | 2022-11-03 | 2,500 | $60.83 | $152.1K | 99,884 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-10-03 | 2022-10-05 | 2,500 | $66.69 | $166.7K | 102,384 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-09-01 | 2022-09-02 | 2,500 | $60.30 | $150.8K | 104,884 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-08-01 | 2022-08-02 | 2,500 | $55.99 | $140.0K | 107,384 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-06-01 | 2022-06-02 | 2,500 | $41.78 | $104.5K | 109,561 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-05-02 | 2022-05-03 | 2,500 | $43.56 | $108.9K | 112,061 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other deriv | 2022-04-21 | 2022-05-03 | 11,250 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other | 2022-04-21 | 2022-05-03 | 1,875 | — | $0 | 114,561 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-03-15 | 2022-03-17 | 7,000 | — | $0 | 50,723 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-03-15 | 2022-03-17 | 375 | $39.57 | $14.8K | 116,436 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-03-15 | 2022-03-17 | 7,000 | $4.31 | $30.2K | 116,811 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-03-01 | 2022-03-02 | 375 | $43.53 | $16.3K | 109,811 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-02-23 | 2022-02-24 | 4,100 | — | $0 | 57,723 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-02-23 | 2022-02-24 | 4,100 | $4.31 | $17.7K | 110,186 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-02-15 | 2022-02-16 | 375 | $45.43 | $17.0K | 106,086 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-02-14 | 2022-02-15 | 3,600 | — | $0 | 61,823 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-02-14 | 2022-02-15 | 3,600 | $4.31 | $15.5K | 106,461 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2022-02-10 | 2022-02-14 | 705 | $47.12 | $33.2K | 102,861 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-02-01 | 2022-02-02 | 375 | $40.58 | $15.2K | 103,566 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2022-01-28 | 2022-02-01 | 650 | $38.59 | $25.1K | 103,941 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2022-01-21 | 2022-01-25 | 36,951 | — | $0 | 36,951 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2022-01-21 | 2022-01-25 | 26,051 | — | $0 | 104,591 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-01-14 | 2022-01-19 | 3,400 | — | $0 | 65,423 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-01-14 | 2022-01-19 | 3,400 | $4.31 | $14.7K | 78,915 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-01-14 | 2022-01-19 | 375 | $40.56 | $15.2K | 78,540 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-01-12 | 2022-01-14 | 1,500 | — | $0 | 68,823 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-01-12 | 2022-01-14 | 3,661 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-01-12 | 2022-01-14 | 1,500 | $4.31 | $6.5K | 75,515 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-01-12 | 2022-01-14 | 3,661 | $3.76 | $13.8K | 74,015 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-01-03 | 2022-01-04 | 375 | $47.31 | $17.7K | 70,354 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-12-15 | 2021-12-17 | 375 | $42.88 | $16.1K | 70,729 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-12-08 | 2021-12-09 | 7,000 | — | $0 | 3,661 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-12-08 | 2021-12-09 | 7,000 | $3.76 | $26.3K | 71,104 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-12-01 | 2021-12-03 | 375 | $42.40 | $15.9K | 64,104 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-11-15 | 2021-11-17 | 625 | $43.50 | $27.2K | 64,479 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-11-01 | 2021-11-02 | 625 | $30.70 | $19.2K | 64,805 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-10-14 | 2021-10-15 | 750 | $34.57 | $25.9K | 65,430 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-10-01 | 2021-10-05 | 750 | $33.26 | $24.9K | 66,180 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-09-28 | 2021-09-29 | 4,000 | — | $0 | 10,661 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-09-28 | 2021-09-29 | 4,000 | $3.76 | $15.0K | 66,930 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-08-02 | 2021-08-03 | 250 | $63.99 | $16.0K | 62,930 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-07-14 | 2021-07-15 | 500 | $64.68 | $32.3K | 63,180 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-07-08 | 2021-07-09 | 250 | $65.68 | $16.4K | 63,680 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-06-28 | 2021-06-29 | 9,000 | — | $0 | 14,661 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-06-28 | 2021-06-29 | 9,000 | $3.76 | $33.8K | 63,930 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-06-14 | 2021-06-15 | 500 | $61.84 | $30.9K | 54,930 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-05-14 | 2021-05-18 | 500 | $45.39 | $22.7K | 55,430 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-05-03 | 2021-05-04 | 600 | $50.73 | $30.4K | 55,614 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-04-14 | 2021-04-15 | 500 | $42.82 | $21.4K | 56,214 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-04-01 | 2021-04-05 | 600 | $43.41 | $26.0K | 56,714 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-03-15 | 2021-03-17 | 500 | $46.77 | $23.4K | 57,314 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-03-05 | 2021-03-08 | 5,000 | — | $0 | 34,073 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-03-05 | 2021-03-08 | 5,000 | $48.62 | $243.1K | 57,814 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-03-05 | 2021-03-08 | 5,000 | $3.20 | $16.0K | 62,814 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-03-01 | 2021-03-03 | 600 | $48.58 | $29.1K | 57,814 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-02-16 | 2021-02-17 | 500 | $46.00 | $23.0K | 58,414 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2021-02-10 | 2021-02-11 | 688 | $47.72 | $32.8K | 58,914 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-02-01 | 2021-02-02 | 600 | $44.00 | $26.4K | 59,602 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 11,250 | — | $0 | 11,250 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 7,500 | — | $0 | 58,327 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 1,875 | — | $0 | 60,202 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-01-25 | 2021-01-26 | 11,500 | — | $0 | 23,661 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2021-01-25 | 2021-01-26 | 3,500 | — | $0 | 39,073 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-01-25 | 2021-01-26 | 3,500 | $3.20 | $11.2K | 39,327 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2021-01-25 | 2021-01-26 | 11,500 | $3.76 | $43.2K | 50,827 | SEC↗ |
| APLS | S Sale | 2021-01-14 | 2021-01-15 | 4,000 | $51.99 | $208.0K | 35,827 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-01-04 | 2021-01-05 | 600 | $57.24 | $34.3K | 39,827 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2020-12-04 | 2020-12-08 | 7,250 | — | $0 | 42,573 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2020-12-04 | 2020-12-08 | 7,250 | $3.20 | $23.2K | 40,427 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2020-12-01 | 2020-12-02 | 600 | $48.25 | $28.9K | 33,177 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2020-11-16 | 2020-11-17 | 5,750 | — | $0 | 49,823 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2020-11-16 | 2020-11-17 | 5,750 | $3.20 | $18.4K | 33,777 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2020-11-02 | 2020-11-03 | 600 | $31.09 | $18.7K | 27,725 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2020-10-01 | 2020-10-02 | 600 | $30.22 | $18.1K | 28,325 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2020-09-01 | 2020-09-02 | 600 | $31.58 | $18.9K | 28,925 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2020-08-03 | 2020-08-05 | 600 | $26.28 | $15.8K | 29,525 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2020-07-01 | 2020-07-02 | 850 | $32.43 | $27.6K | 30,125 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2020-06-15 | 2020-06-16 | 856 | $30.21 | $25.9K | 30,975 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2020-02-10 | 2020-02-12 | 56,250 | — | $0 | 56,250 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2020-02-10 | 2020-02-12 | 9,375 | — | $0 | 31,831 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2019-02-08 | 2019-02-12 | 85,000 | — | $0 | 85,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2018-11-14 | 2018-11-15 | 6,250 | — | $0 | 55,573 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2018-11-14 | 2018-11-15 | 6,250 | $3.20 | $20.0K | 22,456 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other | 2018-05-07 | 2018-05-09 | 7,706 | — | $0 | 16,206 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2018-04-11 | 2018-04-12 | 8,500 | — | $0 | 61,823 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2018-04-11 | 2018-04-12 | 8,500 | $3.20 | $27.2K | 8,500 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2018-02-16 | 2018-02-21 | 200,000 | — | $0 | 200,000 | SEC↗ |